𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Studies of neutralising antibodies to SV40 in human sera

✍ Scribed by P. Minor; P. Pipkin; Z. Jarzebek; W. Knowles

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
100 KB
Volume
70
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

It has been suggested that the low levels of antibody to the simian polyoma virus SV40 found in human sera may be linked to the use of polio vaccines. Panels of sera from areas of the world with different vaccination histories were examined to see if consistent differences could be identified. In a total of 2,054 sera from the United Kingdom, 692 from Africa and 923 from Poland taken between 1985 and 1997, the seroprevalence was generally between 3 and 5%, although exceptionally one collection from Morocco had a prevalence of 100%, and one from Poland of 0.4%. The seroprevalence showed no obvious age‐dependent increase and titres were low compared to post infection animal sera. The results are consistent with previous studies and reveal no general geographically based differences related to possible differences in vaccination history, but the origin of the SV40 antibody in human sera remains to be established. J. Med. Virol. 70:490–495, 2003. Β© 2003 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

The occurrence of SV40-neutralizing anti
The occurrence of SV40-neutralizing antibodies in sera of patients with genitourinary carcinoma
✍ Keerti V. Shah; Loreto D. Palma; Gerald P. Murphy πŸ“‚ Article πŸ“… 1971 πŸ› John Wiley and Sons 🌐 English βš– 398 KB πŸ‘ 1 views

Neutralizing antibodies to simian virus 40 (SV40) were detected in sera of seven of 182 patients studied a t the Roswell Park Memorial Institute. Four of 91 (4.4%) bladder tumor patients, two of 24 (8.3%) patients with prostatic carcinoma, and one of four patients with testicular tumors had antibodi

Population-based study of antibody to th
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
✍ Wendy A. Knowles; Pam Pipkin; Nick Andrews; Andrew Vyse; Philip Minor; David W.G πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 121 KB

## Abstract Molecular studies suggest that the simian polyomavirus SV40 is present in the human population, possibly introduced in contaminated polio vaccine. However, no recent seroepidemiological data exist in England on SV40 or on the two human polyomaviruses, BKV and JCV. A comparative age sero

Differential susceptibility to carcinoge
Differential susceptibility to carcinogen-induced amplification of sv40 and dhfr sequences in sv40-transformed human keratinocytes
✍ Toby G. Rossman; Dora Wolosin πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 990 KB

## Abstract Gene amplification contributes to carcinogenesis by enhancing proto‐oncogene activity and causing chromosomal instability. The ease of detecting amplified tumor‐virus sequences has encouraged use of this system as a surrogate for studying the molecular events involved in endogenous gene